title: Post-market drug safety evidence sources: an analysis of FDA drug safety communications.
authors.forename: Chieko
authors.initials: C
authors.lastname: Ishiguro
authors.forename: Marni
authors.initials: M
authors.lastname: Hall
authors.forename: George A
authors.initials: GA
authors.lastname: Neyarapally
authors.forename: Gerald
authors.initials: G
authors.lastname: Dal Pan
mesh_terms: D017277:Drug Approval; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D011358:Product Surveillance, Postmarketing; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards*